PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of CardiologyDepartment of Internal Medicine and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders Tongji HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan China.\', \'Vita-Saluta San Raffaele UniversityMilano Italy.\', \'Cardio-Oncology ProgramDepartment of MedicineVanderbilt University Medical CenterNashville TN.\', \'De Gasperis Cardio Center and Transplant CenterASST Grande Ospedale Metropolitano NiguardaMilano Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1161/JAHA.120.017736
?:hasPublicationType
?:journal
  • Journal of the American Heart Association
is ?:pmid of
?:pmid
?:pmid
  • 32807002
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.674
?:rankingScore_hIndex
  • 49
is ?:relation_isRelatedTo_publication of
?:title
  • Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all